Publication
Article
This supplement to The American Journal of Managed Care provides information on the diagnosis and management of fibromyalgia. Methods to provide additional education for the medical community, enhance management by health plans, and expand patient access to US Food and Drug Administration-approved fibromyalgia drugs are discussed. The need for updated fibromyalgia treatment guidelines is also discussed.
Participating Faculty
ModeratorRobert P. Navarro, PharmD
Navarro Pharma, LLC
Green Cove Springs, Florida
Roundtable ParticipantsCarole W. Agin, MD, MPA
Pain Medicine
Associate Professor, Clinical Anesthesiology
Stony Brook School of Medicine
Stony Brook University Hospital
Stony Brook, New York
Robert Beltran, MD, MBA
Medical Director, Outpatient Services
Monarch Healthcare
Irvine, California
Ryan K. Bitton, PharmD, MBA
Manager, Pharmacy Services
Health Plan of Nevada/Sierra Health & Life
Las Vegas, Nevada
Micke A. Brown, BSN, RN
Director of Communications
American Pain Foundation
Smithsburg, Maryland
Jon W. Draud, MS, MD
Psychiatrist
Medical Director of Psychiatry and Addiction Medicine
Baptist Hospital and Middle Tennessee Medical Center
Nashville, Tennessee
Jeffrey D. Dunn, PharmD, MBA
Formulary and Contract Manager
SelectHealth, Inc
Salt Lake City, Utah
Joseph Flood, MD
Musculoskeletal Medical Specialists
Clinical Assistant Professor of Internal Medicine
The Ohio State University College of Medicine and Public Health
Columbus, Ohio
Donald Fouts, DO
Family Medicine
Ashville, Ohio
Howard Garber, MD, MPH
Medical Director
Johns Hopkins HealthCare, LLC
Glen Burnie, Maryland
Rae Marie Gleason
Executive Director
National Fibromyalgia Association
Anaheim, California
Don L. Goldenberg, MD
Chief of Rheumatology
Newton-Wellesley Hospital
Professor of Medicine
Tufts University School of Medicine
Newton, Massachusetts
Rakesh Jain, MD, MPH
Director, Adult and Child Psycho-Pharmacology Research
R/D Clinical Research, Inc
Lake Jackson, Texas
Keung Lee, MD
Internal Medicine
Asheboro, North Carolina
Presenters
Ronnie DePue, PharmD, CGP
Managed Care Clinical Specialist
External Scientific Affairs
Forest Research Institute
Jersey City, New Jersey
Ian D'Souza, PhD
Senior Therapeutic Specialist, Psychiatry & Pain
External Scientific Affairs
Forest Research Institute
Jersey City, New Jersey
Faculty DisclosuresCarole W. Agin, MD, MPAPaid advisory board member:
ForestPayment received for manuscript preparation:
ForestSpeaker's bureau:Endo Pharmaceuticals
Robert Beltran, MD, MBA
Paid advisory board member:
ForestPayment received for manuscript preparation:
Forest
Ryan K. Bitton, PharmD, MBA
Paid advisory board member:
ForestPayment received for manuscript preparation:
Forest
Micke A. Brown, BSN, RN
Paid advisory board member:
Forest
Payment received for manuscript preparation:
Forest
Ronnie DePue, PharmD, CGP
Employee:
Forest Research Institute
Stockholder:
Forest Laboratories
Jon W. Draud, MS, MD
National advisory board/speakers' bureau/consultant:
AstraZeneca, Cephalon, Forest, GlaxoSmithKline, Lilly, Pfizer, sanofi-aventis, Takeda, Wyeth PharmaceuticalsPaid advisory board member:
ForestPayment received for manuscript preparation:
Forest
Ian D'Souza, PhD
Employee:
Forest Research Institute
Jeffrey D. Dunn, PharmD, MBA
Paid advisory board member:
Forest
Payment received for manuscript preparation:
Forest
Joseph Flood, MD
Paid advisory board member:
ForestPayment received for manuscript preparation:
Forest
Donald Fouts, DO
Paid advisory board member:
ForestPayment received for manuscript preparation:
Forest
Howard Garber, MD, MPH
Paid advisory board member:
ForestPayment received for manuscript preparation:Forest
Rae Marie Gleason
Paid advisory board member:
ForestPayment received for manuscript preparation:Forest
Don L. Goldenberg, MD
Honoraria:
Forest, Lilly, PfizerMeetings/conference attendance:
Forest, Lilly, PfizerPaid advisory board member:Forest, Lilly, Pfizer
Paid lecturer:PfizerPayment received for manuscript preparation:
Forest
Rakesh Jain, MD, MPH
Honoraria:
Forest, Lilly, PfizerMeetings/conference attendance:
Forest, Lilly, PfizerPaid advisory board member:
Forest, Lilly, PfizerPayment received for manuscript preparation:
Forest
Keung Lee, MD
Paid advisory board member:
ForestPayment received for manuscript preparation:
Forest
Robert P. Navarro, PharmD
Paid advisory board member:
ForestPayment received for manuscript preparation:
Forest
Disclaimer: This publication presents information based on a group consensus relating to specific issues pertaining to the management of fibromyalgia. Perspectives provided may not reflect individual opinions of all attendees.
Forest Laboratories, Inc.
Cypress Bioscience, Inc
This supplement was supported by , New York, NY, and , San Diego, CA, USA.
The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.